Pharvaris Bv Stock Analysis

Pharvaris Stock Analysis Notes

About 88.0% of the company shares are owned by institutional investors. The book value of Pharvaris was at this time reported as 7.35. The company recorded a loss per share of 2.72. Pharvaris BV had not issued any dividends in recent years. Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company was incorporated in 2015 and is based in Leiden, the Netherlands. Pharvaris is traded on NASDAQ Exchange in the United States. To find out more about Pharvaris BV contact CPA MBA at 31 71 203 6410 or learn more at https://pharvaris.com.

Pharvaris BV Investment Alerts

Pharvaris BV Upcoming and Recent Events

Pharvaris Largest EPS Surprises

View All Earnings Estimates

Pharvaris Environmental, Social, and Governance (ESG) Scores

Pharvaris Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.31 B.

Pharvaris Profitablity

Management Efficiency

Pharvaris BV has return on total asset (ROA) of (0.2679) % which means that it has lost $0.2679 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4505) %, meaning that it created substantial loss on money invested by shareholders. Pharvaris' management efficiency ratios could be used to measure how well Pharvaris manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.27 in 2024. Return On Capital Employed is likely to drop to -0.26 in 2024. At this time, Pharvaris' Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 885.3 K in 2024, whereas Return On Tangible Assets are likely to drop (0.27) in 2024.

Technical Drivers

As of the 28th of November, Pharvaris holds the Coefficient Of Variation of 907.19, semi deviation of 2.99, and Risk Adjusted Performance of 0.0923. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pharvaris, as well as the relationship between them. Please check Pharvaris BV market risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Pharvaris BV is priced some-what accurately, providing market reflects its current price of 22.36 per share. Given that Pharvaris has jensen alpha of 0.2454, we recommend you to check out Pharvaris BV's recent market performance to make sure the company can sustain itself at a future point.

Pharvaris BV Price Movement Analysis

Pharvaris Outstanding Bonds

Pharvaris Predictive Daily Indicators

Pharvaris Corporate Filings

Pharvaris Forecast Models

Pharvaris' time-series forecasting models are one of many Pharvaris' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Pharvaris' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Pharvaris prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Pharvaris shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Pharvaris. By using and applying Pharvaris Stock analysis, traders can create a robust methodology for identifying Pharvaris entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Pharvaris analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Pharvaris analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Pharvaris BV stock analysis indicators help investors evaluate how Pharvaris stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Pharvaris shares will generate the highest return on investment. By understating and applying Pharvaris stock analysis, traders can identify Pharvaris position entry and exit signals to maximize returns.

When running Pharvaris' price analysis, check to measure Pharvaris' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharvaris is operating at the current time. Most of Pharvaris' value examination focuses on studying past and present price action to predict the probability of Pharvaris' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharvaris' price. Additionally, you may evaluate how the addition of Pharvaris to your portfolios can decrease your overall portfolio volatility.